Genelux Investor Presentation Deck

Genelux has Partnered with Newsoara BioPharma Co., Ltd GENELUX GENELUX NEWSOARA 恒翼生物医药 Benny Li, PhD Founder and Chief Executive Officer 20+ yrs. global and China local pharma Former VP, GM of Takeda China Development Center and SVP, Executive GM of R&D at Hansoh Pharmaceuticals Former Head of Clinical Development & Medical Affairs in Asia at Alcon/Novartis $850 Million Valuation 7 Pipelines. 12 Indications NEWSOARA HIGHLIGHTS Top 10 Blue-chip Biotech Investors 5 Phase IIb/I|| 2 Phase II 2023 IPO Planned Newsoara has paid $11M to date and GNLX is eligible for additional development, regulatory and sales milestone payments and up to mid-double-digit percentages royalties on net sales 21

View entire presentation